Ledger.Open graph →
SEC Form D · filed March 13, 2020

Elicio Therapeutics, Inc

Offering
$8.4M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Robert Ruffolo · Cambridge, MADirectorIsaac Kohlberg · Cambridge, MADirectorDaniel Geffken · Cambridge, MAExec · DirectorJulian Adams · Cambridge, MAExec · DirectorRobert Connelly · Cambridge, MAExec · DirectorKevin W. Schuyler · Charlottesville, VADirectorJoseph Woo · PALO ALTO, CAExec · DirectorMark Alviano · Cary, NCExec · DirectorHenry Ellenbogen · Chevy Chase, MDExec · DirectorWcp Holdings LLC · Reston, VADirectorCarol Lizak · San Francisco, CAExec · DirectorSteven King · San Francisco, CADirectorJonathan Wolin · San Francisco, CAExec · DirectorJames Bochnowski · San Francisco, CAExec · DirectorJohn Micek, Iii · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗